Literature DB >> 23134338

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis.

E Daudén1, S Castañeda, C Suárez, J García-Campayo, A J Blasco, M D Aguilar, C Ferrándiz, L Puig, J L Sánchez-Carazo.   

Abstract

BACKGROUND: The relationship between psoriasis and associated diseases has drawn particular interest in recent years. To provide appropriate management of psoriasis from an early stage, it is necessary to include prompt diagnosis of concomitant disease and to prevent and treat any comorbidity found. Such an integrated approach also serves to ensure that the drugs used to treat associated diseases do not interfere with the management of psoriasis, and vice versa.
OBJECTIVE: To provide the dermatologist a guide focuses specifically on the diagnosis and management of the diseases most often found in patients with psoriasis.
METHODS: The selection of the diseases, and corresponding supporting research, to be included was based on a systematic review of the literature. The recommendations on diagnostic criteria are based on the main clinical practice guidelines for each of the diseases discussed as well as on the recommendations of a clinical expert advisory group. The information regarding the repercussions of psoriasis treatments on associated comorbid diseases was obtained from the summary of product characteristics of each drug. In turn, the statements concerning the impact of the associated diseases, and their treatment, on psoriasis are based on the review of the literature.
RESULTS: This guide is a precise, easy-to-use tool for systematizing the diagnosis of comorbidity in patients with psoriasis and facilitate decision making regarding referral and treatment of patients diagnosed with an associated disease.
CONCLUSION: The application of this guide not only will benefit psoriasis patients' health and quality of life but it will also optimize available resources.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2012        PMID: 23134338     DOI: 10.1111/jdv.12024

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  25 in total

Review 1.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  Association of Psoriasis With Comorbidity Development in Children With Psoriasis.

Authors:  Megha M Tollefson; Holly K Van Houten; Dennis Asante; Xiaoxi Yao; Hilal Maradit Kremers
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

3.  Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.

Authors:  Juan Carlos Torre-Alonso; Loreto Carmona; Mireia Moreno; Eva Galíndez; Jesús Babío; Pedro Zarco; Luis Linares; Eduardo Collantes-Estevez; Manuel Fernández Barrial; Juan Carlos Hermosa; Pablo Coto; Carmen Suárez; Raquel Almodóvar; Jesús Luelmo; Santos Castañeda; Jordi Gratacós
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

4.  Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene.

Authors:  Niamh Kearney; Brian Kirby
Journal:  Am J Clin Dermatol       Date:  2022-08-23       Impact factor: 6.233

5.  Clinicians' perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study.

Authors:  Daniel Sumpton; Elyssa Hannan; Ayano Kelly; David Tunnicliffe; Andrew Ming; Geraldine Hassett; Jonathan C Craig; Allison Tong
Journal:  Clin Rheumatol       Date:  2020-09-15       Impact factor: 2.980

Review 6.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 7.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

8.  [Comorbidities in psoriatic arthritis].

Authors:  W-H Boehncke; S Boehncke
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

9.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

10.  Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis.

Authors:  Filomena Morisco; Maria Guarino; Serena La Bella; Luisa Di Costanzo; Nicola Caporaso; Fabio Ayala; Nicola Balato
Journal:  BMC Gastroenterol       Date:  2014-12-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.